RecallRadar

FDA Drug recall D-0555-2026

Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabeled by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-634-30, Markete…

On 2026-06-10 the FDA classified a Class II recall of Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabeled by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-634-30, Markete… by Asclemed Usa, citing CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0555-2026
ClassificationClass II
Statusongoing
Initiated2026-05-14
Published2026-06-10
Last updated2026-09-13 11:52 UTC
CompanyAsclemed Usa
DistributionUS

Product

Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabeled by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-634-30, Marketed by: Ajanta Pharma USA Inc.

Reason

CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.

Identifiers

ndc76420-633-20
ndc76420-633-30
ndc76420-633-60
ndc76420-633-90
ndc76420-633-01
ndc76420-633-05
ndc76420-633-00
ndc76420-634-20
ndc76420-634-30
ndc76420-634-60
ndc76420-634-90
ndc76420-634-01
ndc76420-634-00
ndc76420-636-20
ndc76420-636-30
ndc76420-636-60
ndc76420-636-90
ndc76420-636-01
ndc76420-623-20
ndc76420-623-30
ndc76420-623-60
ndc76420-623-90
ndc76420-623-01
ndc76420-623-00
code_infoLot # 050725G-30 & 050725F-30, Exp Date: 06/30/2026

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0555-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.